Search

Your search keyword '"Agache, I."' showing total 849 results

Search Constraints

Start Over You searched for: Author "Agache, I." Remove constraint Author: "Agache, I."
849 results on '"Agache, I."'

Search Results

101. Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper

104. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen)

105. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases

106. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

107. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

108. ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

109. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

110. 2019 ARIA Care pathways for allergen immunotherapy

111. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 2)

112. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

113. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

114. The importance of real-life research in respiratory medicine: Manifesto of the Respiratory Effectiveness Group

115. Changing the history of anaphylaxis mortality statistics through the World Health Organization's International Classification of Diseases–11

116. 2019 ARIA Care pathways for allergen immunotherapy [ARIA-Versorgungspfade für die Allergenimmuntherapie 2019]

117. Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases

118. 2019 ARIA Care pathways for allergen immunotherapy

119. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 1)

120. Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018

121. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

122. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

123. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018) : Change management in allergic rhinitis and asthma multimorbidity using mobile technology

124. Adherence to treatment in allergic rhinitis using mobile technology : The MASK Study

125. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 1)

126. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 2)

127. Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases

128. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.

129. Highlights and recent developments in skin allergy and related diseases in EAACI journals (2018)

132. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma

133. Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018

135. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement

136. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

137. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis

138. Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS

139. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

140. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy

141. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy

142. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

143. ARIA Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

144. Influenza burden, prevention, and treatment in asthma-A scoping review by the EAACI Influenza in asthma task force

145. Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study

146. Mask 2017: Aria Digitally-Enabled, Integrated, Person-Centred Care For Rhinitis And Asthma Multimorbidity Using Real-World-Evidence

147. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy

148. Differences in Reporting the Ragweed Pollen Season Using Google Trends across 15 Countries

149. Impact Of Rhinitis On Work Productivity: A Systematic Review

150. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

Catalog

Books, media, physical & digital resources